Altered glycosylation in pancreatic cancer and beyond is a research paper published in The Journal of Experimental Medicine (2022). On theSindex it has a DataRank of 2.3. It has been cited 92 times, with 81 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.680
From this paper's citation signal
Citation Network Contribution
1.6
From 58 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 81 citers.
National Cancer Institute
Grant: R00CA024725
National Cancer Institute
Grant: P30DK120515
National Cancer Institute
Grant: T32CA009370
National Cancer Institute
Grant: T32GM133351
Pancreatic Cancer Action Network
Grant: 19-20-ENGL
Lustgarten Foundation
Grant: 21-20-67-ENGL
Tobacco-Related Disease Research Program
Grant: T31KT1898
Padres Pedal the Cause
Grant: C3 #PTC2020
NCI NIH HHS
Grant: R00 CA204725
NCI NIH HHS
Grant: P30 CA014195
National Institutes of Health
Grant: 5T32CA009370-06
CELL REGULATION DIFFERENTIATION AND CANCER
National Institutes of Health
Grant: 5T32GM133351-04
Pathways in Biological Sciences Training Program
National Institutes of Health
Grant: 5P30DK120515-04
San Diego Digestive Diseases Research Center
Emerald Foundation, Inc
Salkexcellerator
Mission Cure Capital, LLC
NIH HHS
American Association for Cancer Research
Rose Hills Foundation
Mark Foundation for Cancer Research
National Institutes of Health
NIH HHS
FWCI
6.04
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals